Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more
Jiangsu Apon Medical Technology Co Ltd Class A (300753) - Total Assets
Latest total assets as of September 2025: CN¥839.64 Million CNY
Based on the latest financial reports, Jiangsu Apon Medical Technology Co Ltd Class A (300753) holds total assets worth CN¥839.64 Million CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Jiangsu Apon Medical Technology Co Ltd Class A - Total Assets Trend (2014–2024)
This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Jiangsu Apon Medical Technology Co Ltd Class A - Asset Composition Analysis
Current Asset Composition (December 2024)
Jiangsu Apon Medical Technology Co Ltd Class A's total assets of CN¥839.64 Million consist of 53.1% current assets and 46.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 23.4% |
| Accounts Receivable | CN¥166.83 Million | 19.3% |
| Inventory | CN¥62.71 Million | 7.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥36.30 Million | 4.2% |
| Goodwill | CN¥54.71 Million | 6.3% |
Asset Composition Trend (2014–2024)
This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jiangsu Apon Medical Technology Co Ltd Class A's current assets represent 53.1% of total assets in 2024, a decrease from 70.3% in 2014.
- Cash Position: Cash and equivalents constituted 23.4% of total assets in 2024, up from 10.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 1.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 19.3% of total assets.
Jiangsu Apon Medical Technology Co Ltd Class A Competitors by Total Assets
Key competitors of Jiangsu Apon Medical Technology Co Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Jiangsu Apon Medical Technology Co Ltd Class A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Jiangsu Apon Medical Technology Co Ltd Class A generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Jiangsu Apon Medical Technology Co Ltd Class A generates $ 1.25 in net profit.
Jiangsu Apon Medical Technology Co Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.23 | 3.89 | 6.14 |
| Quick Ratio | 2.82 | 3.17 | 5.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥283.71 Million | CN¥ 323.20 Million | CN¥ 438.06 Million |
Jiangsu Apon Medical Technology Co Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Jiangsu Apon Medical Technology Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.44 |
| Latest Market Cap to Assets Ratio | 0.38 |
| Asset Growth Rate (YoY) | 0.5% |
| Total Assets | CN¥863.49 Million |
| Market Capitalization | $325.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jiangsu Apon Medical Technology Co Ltd Class A's assets below their book value (0.38 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jiangsu Apon Medical Technology Co Ltd Class A's assets grew by 0.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below shows the annual total assets of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥863.49 Million | +0.46% |
| 2023-12-31 | CN¥859.57 Million | -1.22% |
| 2022-12-31 | CN¥870.21 Million | -3.21% |
| 2021-12-31 | CN¥899.06 Million | +8.68% |
| 2020-12-31 | CN¥827.24 Million | +9.19% |
| 2019-12-31 | CN¥757.64 Million | +10.13% |
| 2018-12-31 | CN¥687.96 Million | +106.43% |
| 2017-12-31 | CN¥333.26 Million | +13.16% |
| 2016-12-31 | CN¥294.51 Million | +63.36% |
| 2015-12-31 | CN¥180.28 Million | +55.68% |
| 2014-12-31 | CN¥115.80 Million | -- |